Publication | Closed Access

Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin

InflammationPsoriasis PatientsAutoimmune DiseaseLesional SkinMedicinePeripheral Blood LeukocytesImmunologyImmune RegulationClinical DermatologyAutoimmunityDermatologyImmunotherapyPsoriatic Arthritis